Paxlovid reduces risk of long-term health problems, death from COVID-19 – Washington University School of Medicine in St. Louis

Drug recommended to prevent severe complications of virus

The antiviral drug Paxlovid reduces the risk of getting long COVID

Trying to Stop Long COVID Before It Even Starts - The Atlantic

Four years on, long COVID still confounds us. Here's what we now

Paxlovid Cuts Risk of Long COVID, Study Finds

Nirmatrelvir tied to 26% lower risk of long COVID, 47% lower risk

Effect of Paxlovid Treatment on Long COVID Onset: An EHR-Based

Leana Wen M.D. M.Sc. on LinkedIn: #longcovid #covidtreatment

Here's the latest good and bad news about COVID-19 drugs

Paxlovid lowered COVID hospitalizations, deaths in vaccinated

Many long-COVID symptoms linger even after 2 years, new study

Opinion Paxlovid might be even more important than the new covid shot - The Washington Post

Racial and Ethnic Disparities in Receipt of Medications for Treatment of COVID-19 — United States, March 2020–August 2021

Pfizer's Paxlovid antiviral drug lowered risk of long COVID

Fluvoxamine, an old drug that costs just a few dollars, might help

Merck's COVID pill loses its lustre: what that means for the pandemic